{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2022,5,28]],"date-time":"2022-05-28T13:41:17Z","timestamp":1653745277899},"reference-count":27,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,5,28]],"date-time":"2022-05-28T00:00:00Z","timestamp":1653696000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,5,28]],"date-time":"2022-05-28T00:00:00Z","timestamp":1653696000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["AIDS Res Ther"],"published-print":{"date-parts":[[2022,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>People living with HIV (PLWHIV) commencing antiretroviral therapy (ART) in sub-Saharan Africa experience significant mortality within the first year. Previously, identified risk factors for mortality may be biased towards these patients, as compared to those who experience late mortality.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Aim<\/jats:title>\n                <jats:p>To compare risk factors for early and late mortality in PLWHIV commencing ART.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>A retrospective cohort study of ART-na\u00efve patients aged\u2009\u2265\u200918 years from an outpatient HIV clinic in Zimbabwe. Data were collected between January 2010 and January 2019. Predictors for early (\u2264\u20091 year) and late mortality (&gt;\u20091 year) were determined by multivariable cox proportional hazards analyses, with patients censored at 1 year and landmark analysis after 1 year, respectively.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>Three thousand and thirty-nine\u00a0PLWHIV were included in the analysis. Over a median follow-up of 4.6 years (IQR 2.5\u20136.9), there was a mortality rate of 8.8%, with 50.4% of deaths occurring within 1\u00a0year. Predictors of early mortality included CD4 count\u2009&lt;\u200950 cells\/\u00b5L (HR 1.84, 95% CI 1.24\u20132.72, p\u2009&lt;\u20090.01), WHO Stage III (HR 2.05, 95% CI 1.28\u20133.27, p\u2009&lt;\u20090.01) or IV (HR 2.83, 95% CI 1.67\u20134.81, p\u2009&lt;\u20090.01), and eGFR\u2009&lt;\u200990 mL\/min\/1.73\u00a0m<jats:sup>2<\/jats:sup> (HR 2.48, 95% CI 1.56\u20133.96, p\u2009&lt;\u20090.01). Other than age (p\u2009&lt;\u20090.01), only proteinuria (HR 2.12, 95% CI 1.12\u20134.01, p\u2009=\u20090.02) and diabetes mellitus (HR 3.51, 95% CI 1.32\u20139.32, p\u2009=\u20090.01) were associated with increased risk of late mortality.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusions<\/jats:title>\n                <jats:p>\nTraditional markers of mortality risk in patients commencing ART appear to be limited to early mortality. Proteinuria and diabetes are some of the few predictors of late mortality, and should be incorporated into routine screening of patients commencing ART.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s12981-022-00445-4","type":"journal-article","created":{"date-parts":[[2022,5,28]],"date-time":"2022-05-28T13:05:43Z","timestamp":1653743143000},"update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Comparison of predictors for early and late mortality in adults commencing HIV antiretroviral therapy in Zimbabwe: a retrospective cohort study"],"prefix":"10.1186","volume":"19","author":[{"given":"Bradley W.","family":"Byers","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Douglas","family":"Drak","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tinei","family":"Shamu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cleophas","family":"Chimbetete","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rumbi","family":"Dahwa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David M.","family":"Gracey","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2022,5,28]]},"reference":[{"key":"445_CR1","volume-title":"HIV estimates with uncertainty bounds 1990\u20132020. Global AIDS Update 2020","author":"UNAIDS","year":"2020","unstructured":"UNAIDS. HIV estimates with uncertainty bounds 1990\u20132020. Global AIDS Update 2020. Geneva: UNAIDS; 2020."},{"issue":"15","key":"445_CR2","doi-asserted-by":"publisher","first-page":"1897","DOI":"10.1097\/QAD.0b013e32830007cd","volume":"22","author":"SD Lawn","year":"2008","unstructured":"Lawn SD, Harries AD, Anglaret X, Myer L, Wood R. Early mortality among adults accessing antiretroviral treatment programmes in sub-Saharan Africa. AIDS. 2008;22(15):1897\u2013908.","journal-title":"AIDS"},{"key":"445_CR3","first-page":"5415298","volume":"2017","author":"M Biset Ayalew","year":"2017","unstructured":"Biset Ayalew M. Mortality and its predictors among HIV infected patients taking antiretroviral treatment in Ethiopia: a systematic review. AIDS Res Treat. 2017;2017:5415298.","journal-title":"AIDS Res Treat"},{"issue":"9513","key":"445_CR4","doi-asserted-by":"publisher","first-page":"817","DOI":"10.1016\/S0140-6736(06)68337-2","volume":"367","author":"P Braitstein","year":"2006","unstructured":"Braitstein P, Brinkhof MW, Dabis F, Schechter M, Boulle A, Miotti P, et al. Mortality of HIV-1-infected patients in the first year of antiretroviral therapy: comparison between low-income and high-income countries. Lancet. 2006;367(9513):817\u201324.","journal-title":"Lancet"},{"issue":"1","key":"445_CR5","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1016\/j.jinf.2013.03.008","volume":"67","author":"FS Sarfo","year":"2013","unstructured":"Sarfo FS, Keegan R, Appiah L, Shakoor S, Phillips R, Norman B, et al. High prevalence of renal dysfunction and association with risk of death amongst HIV-infected Ghanaians. J Infect. 2013;67(1):43\u201350.","journal-title":"J Infect"},{"issue":"14","key":"445_CR6","doi-asserted-by":"publisher","first-page":"1821","DOI":"10.1097\/QAD.0b013e328307a051","volume":"22","author":"LB Mulenga","year":"2008","unstructured":"Mulenga LB, Kruse G, Lakhi S, Cantrell RA, Reid SE, Zulu I, et al. Baseline renal insufficiency and risk of death among HIV-infected adults on antiretroviral therapy in Lusaka, Zambia. AIDS. 2008;22(14):1821\u20137.","journal-title":"Zambia. AIDS"},{"issue":"9","key":"445_CR7","doi-asserted-by":"publisher","first-page":"604","DOI":"10.7326\/0003-4819-150-9-200905050-00006","volume":"150","author":"AS Levey","year":"2009","unstructured":"Levey AS, Stevens LA, Schmid CH, Zhang YL, Castro AF, Feldman HI, et al. A new equation to estimate glomerular filtration rate. Ann Intern Med. 2009;150(9):604\u201312.","journal-title":"Ann Intern Med"},{"issue":"1","key":"445_CR8","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1111\/j.1365-3156.2008.02183.x","volume":"14","author":"I Sieleunou","year":"2009","unstructured":"Sieleunou I, Souleymanou M, Schonenberger AM, Menten J, Boelaert M. Determinants of survival in AIDS patients on antiretroviral therapy in a rural centre in the Far-North Province, Cameroon. Trop Med Int Health. 2009;14(1):36\u201343.","journal-title":"Trop Med Int Health"},{"key":"445_CR9","doi-asserted-by":"publisher","DOI":"10.1136\/bmjopen-2013-003210","author":"V Poka-Mayap","year":"2013","unstructured":"Poka-Mayap V, Pefura-Yone EW, Kengne AP, Kuaban C. Mortality and its determinants among patients infected with HIV-1 on antiretroviral therapy in a referral centre in Yaounde, Cameroon: a retrospective cohort study. BMJ Open. 2013. https:\/\/doi.org\/10.1136\/bmjopen-2013-003210.","journal-title":"BMJ Open"},{"issue":"5","key":"445_CR10","doi-asserted-by":"publisher","first-page":"296","DOI":"10.1177\/1545109711406733","volume":"11","author":"G Chalamilla","year":"2012","unstructured":"Chalamilla G, Hawkins C, Okuma J, Spiegelman D, Aveika A, Christian B, et al. Mortality and treatment failure among HIV-infected adults in Dar Es Salaam, Tanzania. J Int Assoc Physicians AIDS Care. 2012;11(5):296\u2013304.","journal-title":"J Int Assoc Physicians AIDS Care"},{"issue":"3","key":"445_CR11","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1097\/QAI.0b013e3182303716","volume":"58","author":"DM Moore","year":"2011","unstructured":"Moore DM, Yiannoutsos CT, Musick BS, Tappero J, Degerman R, Campbell J, et al. Determinants of early and late mortality among HIV-infected individuals receiving home-based antiretroviral therapy in rural Uganda. J Acquir Immune Defic Syndr. 2011;58(3):289\u201396.","journal-title":"J Acquir Immune Defic Syndr"},{"issue":"12","key":"445_CR12","doi-asserted-by":"publisher","first-page":"1615","DOI":"10.1097\/01.aids.0000131375.21070.06","volume":"18","author":"MA French","year":"2004","unstructured":"French MA, Price P, Stone SF. Immune restoration disease after antiretroviral therapy. AIDS. 2004;18(12):1615\u201327.","journal-title":"AIDS"},{"issue":"2","key":"445_CR13","first-page":"67","volume":"5","author":"SA Shelburne III","year":"2003","unstructured":"Shelburne SA, Hamill RJ. The immune reconstitution inflammatory syndrome. AIDS Rev. 2003;5(2):67\u201379.","journal-title":"AIDS Rev"},{"issue":"3","key":"445_CR14","doi-asserted-by":"publisher","first-page":"418","DOI":"10.1086\/499356","volume":"42","author":"I Ratnam","year":"2006","unstructured":"Ratnam I, Chiu C, Kandala NB, Easterbrook PJ. Incidence and risk factors for immune reconstitution inflammatory syndrome in an ethnically diverse HIV type 1-infected cohort. Clin Infect Dis. 2006;42(3):418\u201327.","journal-title":"Clin Infect Dis"},{"issue":"11","key":"445_CR15","doi-asserted-by":"publisher","first-page":"e40623","DOI":"10.1371\/journal.pone.0040623","volume":"7","author":"LJ Haddow","year":"2012","unstructured":"Haddow LJ, Moosa MY, Mosam A, Moodley P, Parboosing R, Easterbrook PJ. Incidence, clinical spectrum, risk factors and impact of HIV-associated immune reconstitution inflammatory syndrome in South Africa. PLoS One. 2012;7(11):e40623.","journal-title":"PLoS One"},{"issue":"6","key":"445_CR16","doi-asserted-by":"publisher","first-page":"965","DOI":"10.1086\/605500","volume":"49","author":"B Castelnuovo","year":"2009","unstructured":"Castelnuovo B, Manabe YC, Kiragga A, Kamya M, Easterbrook P, Kambugu A. Cause-specific mortality and the contribution of immune reconstitution inflammatory syndrome in the first 3 years after antiretroviral therapy initiation in an urban African cohort. Clin Infect Dis. 2009;49(6):965\u201372.","journal-title":"Clin Infect Dis"},{"issue":"5","key":"445_CR17","doi-asserted-by":"publisher","first-page":"601","DOI":"10.1097\/QAD.0b013e3282f4a607","volume":"22","author":"DM Murdoch","year":"2008","unstructured":"Murdoch DM, Venter WD, Feldman C, Van Rie A. Incidence and risk factors for the immune reconstitution inflammatory syndrome in HIV patients in South Africa: a prospective study. AIDS. 2008;22(5):601\u201310.","journal-title":"AIDS"},{"issue":"6","key":"445_CR18","doi-asserted-by":"publisher","first-page":"513","DOI":"10.1016\/j.semnephrol.2008.08.005","volume":"28","author":"CM Wyatt","year":"2008","unstructured":"Wyatt CM, Klotman PE, D\u2019Agati VD. HIV-associated nephropathy: clinical presentation, pathology, and epidemiology in the era of antiretroviral therapy. Semin Nephrol. 2008;28(6):513\u201322.","journal-title":"Semin Nephrol"},{"key":"445_CR19","doi-asserted-by":"publisher","first-page":"284","DOI":"10.1186\/1471-2334-14-284","volume":"14","author":"GS Bloomfield","year":"2014","unstructured":"Bloomfield GS, Hogan JW, Keter A, Holland TL, Sang E, Kimaiyo S, et al. Blood pressure level impacts risk of death among HIV seropositive adults in Kenya: a retrospective analysis of electronic health records. BMC Infect Dis. 2014;14:284.","journal-title":"BMC Infect Dis"},{"issue":"10","key":"445_CR20","doi-asserted-by":"publisher","first-page":"674","DOI":"10.1111\/hiv.12934","volume":"21","author":"JM Bleasel","year":"2020","unstructured":"Bleasel JM, Heron JE, Shamu T, Chimbetete C, Dahwa R, Gracey DM. Body mass index and noninfectious comorbidity in HIV-positive patients commencing antiretroviral therapy in Zimbabwe. HIV Med. 2020;21(10):674\u20139.","journal-title":"HIV Med"},{"issue":"7","key":"445_CR21","doi-asserted-by":"publisher","first-page":"782","DOI":"10.1001\/jama.296.7.782","volume":"296","author":"JS Stringer","year":"2006","unstructured":"Stringer JS, Zulu I, Levy J, Stringer EM, Mwango A, Chi BH, et al. Rapid scale-up of antiretroviral therapy at primary care sites in Zambia: feasibility and early outcomes. JAMA. 2006;296(7):782\u201393.","journal-title":"JAMA"},{"issue":"18","key":"445_CR22","doi-asserted-by":"publisher","first-page":"2355","DOI":"10.1097\/QAD.0b013e32801086b0","volume":"20","author":"R Zachariah","year":"2006","unstructured":"Zachariah R, Fitzgerald M, Massaquoi M, Pasulani O, Arnould L, Makombe S, et al. Risk factors for high early mortality in patients on antiretroviral treatment in a rural district of Malawi. AIDS. 2006;20(18):2355\u201360.","journal-title":"AIDS"},{"key":"445_CR23","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1186\/1471-2334-8-52","volume":"8","author":"A Johannessen","year":"2008","unstructured":"Johannessen A, Naman E, Ngowi BJ, Sandvik L, Matee MI, Aglen HE, et al. Predictors of mortality in HIV-infected patients starting antiretroviral therapy in a rural hospital in Tanzania. BMC Infect Dis. 2008;8:52.","journal-title":"BMC Infect Dis"},{"key":"445_CR24","volume-title":"The state of food insecurity in the world","author":"Food and Agriculture Organization of the United Nations","year":"2021","unstructured":"Food and Agriculture Organization of the United Nations. The state of food insecurity in the world. Rome: FAO; 2021."},{"issue":"4","key":"445_CR25","doi-asserted-by":"publisher","first-page":"507","DOI":"10.1097\/QAI.0b013e3181b32baf","volume":"53","author":"JR Koethe","year":"2010","unstructured":"Koethe JR, Lukusa A, Giganti MJ, Chi BH, Nyirenda CK, Limbada MI, et al. Association between weight gain and clinical outcomes among malnourished adults initiating antiretroviral therapy in Lusaka, Zambia. J Acquir Immune Defic Syndr. 2010;53(4):507\u201313.","journal-title":"J Acquir Immune Defic Syndr"},{"issue":"4","key":"445_CR26","doi-asserted-by":"publisher","first-page":"1138S-42S","DOI":"10.3945\/ajcn.2010.28608D","volume":"91","author":"JR Koethe","year":"2010","unstructured":"Koethe JR, Heimburger DC. Nutritional aspects of HIV-associated wasting in sub-Saharan Africa. Am J Clin Nutr. 2010;91(4):1138S-42S.","journal-title":"Am J Clin Nutr"},{"issue":"10","key":"445_CR27","doi-asserted-by":"publisher","first-page":"e0223411","DOI":"10.1371\/journal.pone.0223411","volume":"14","author":"RA Silverman","year":"2019","unstructured":"Silverman RA, John-Stewart GC, Beck IA, Milne R, Kiptinness C, McGrath CJ, et al. Predictors of mortality within the first year of initiating antiretroviral therapy in urban and rural Kenya: A prospective cohort study. PLoS ONE. 2019;14(10):e0223411.","journal-title":"PLoS ONE"}],"container-title":["AIDS Research and Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12981-022-00445-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12981-022-00445-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12981-022-00445-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,5,28]],"date-time":"2022-05-28T13:19:46Z","timestamp":1653743986000},"score":1,"resource":{"primary":{"URL":"https:\/\/aidsrestherapy.biomedcentral.com\/articles\/10.1186\/s12981-022-00445-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,5,28]]},"references-count":27,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2022,12]]}},"alternative-id":["445"],"URL":"https:\/\/doi.org\/10.1186\/s12981-022-00445-4","relation":{},"ISSN":["1742-6405"],"issn-type":[{"value":"1742-6405","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,5,28]]},"assertion":[{"value":"28 January 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 April 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 May 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Ethical approval for this study was granted by the Medical Research Council of Zimbabwe (MRCZ\/E\/258). All research activities were conducted in accordance with the Declaration of Helsinki.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"23"}}